Checkpoint Inhibitors Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Global Checkpoint Inhibitors Market is expected to grow at a CAGR of 14.5% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Checkpoint Inhibitors Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players in the market are as follows:

KEY PLAYERS

ALX ONCOLOGY

AGENUS INC.

ANAPTYS BIO

BEIGENE

BIOCAD

CSTONE PHARMACEUTICALS

CRESCENDO BIOLOGICS LTD.

F-STAR BIOTECHNOLOGY

FORTY SEVEN INC.

IMMUTEP LTD.

INHIBRX

MACROGENICS INC.

OSE IMMUNOTHERAPEUTIC

REGENERON PHARMACEUTICALS INC.

SEATTLE GENETICS INC.

SORRENTO THERAPEUTICS, INC.

SHANGHAI CELL THERAPY

SYMPHOGEN A/S

SURFACE ONCOLOGY

TESARO INC.

TRILLIUM THERAPEUTICS

XENCOR

Scope of the Market

Drug Class Market

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW)